Eurocord Partners

1 - Centre Scientifique de Monaco (CSM)

Motivated by the desire of Prince Rainier III, Prince of Monaco, the Centre Scientifique de Monaco was established in 1960, to provide the Principauté of Monaco the tools to conduct scientific research oriented towards conservation and protection of marine life. Since its creation, the CSM has specialized in the study of the coral ecosystems (tropical and Mediterranean) in relation to global climatic changes. Since November 2010, the Centre Scientifique de Monaco, hosted the MONACORD as part of its Medical Biology division. Monacord is an Eurocord clinical research group which has established at the CSM the “International Observatory on Sickle Cell Disease”. The group’s objective is to improve the management and quality of care in Sickle Cell Disease (SCD), and to transfer these practices to countries with limited health care access.

2 - Institut Universitaire d'Hématologie (IUH) – Paris Diderot

The University Institute of Hematology (IUH) was established in 1958 by Professor Jean BERNARD and Professor Jean Dausset (Nobel prise). Affiliated to the University Paris Diderot - Paris 7, the IUH goals are research and academic training to improve the care of patients, particularly in the fields of hematology, oncology, immunology, virology, genetics and biotechnical therapies.

Training at the IUH is carried out in the context of a graduate school (Biology and Biotechnology of the University Paris Diderot - Paris 7 and Paris Descartes), the European School of Hematology (ESH) and master level programmes. Key themes of the IUH are Hematology, Oncology and Histocompatibility.

The IUH education programs are supported by Doctoral School (Biology and Biotechnology) of the University Paris Diderot - Paris 7 and Paris Descartes, as well as the European school of Hematology (ESH). The IUH is a founding member of the Cancéropôle Ile-de-France. The IUH is one of the first European leaders in Onco-hematology and Hematopoietic Stem Cell Transplantation.

For More information, please refer to the IUH website ( )

3 - Maladies Auto-Immunes et Therapie Cellulaire (MATHEC):

The MATHEC network was established over a 15 year span through collaborations between experts from the following French accredited centers for the practice of hematopoietic stem cell transplants in autoimmune diseases: Paris Saint-Louis and Saint-Antoine, Lille, Strasbourg, Poitiers, Toulouse, Marseille, Nantes, Clermont-Ferrand, and Grenoble.

The MATHEC network, which is focused on the development of innovative stem cell therapies for the treatment of non-malignant autoimmune and auto-inflammatory diseases, is coordinated at Saint-Louis Hospital, department of internal medicine, autoimmune diseases and vascular pathology (UF04 , Pr Farge). In November 2017, Saint-Louis hospital was appointed as a “Center of Reference for Rare Systemic Autoimmune Diseases of l’Ile-de-France, FAI2R sector.

The members of the MATHEC Association are working to develop the use of bone marrow transplantation and cell therapy for the treatment of autoimmune and auto-inflammatory diseases and to promote French centers of excellence internationally.

4 - European School of Haematology (ESH)

The European School of Haematology (ESH) is a not-for-profit institution for continuing education founded in 1985 to promote and facilitate access to state-of-the-art and cutting-edge knowledge in hematology and related disciplines at the European level. ESH Conferences present state-of-the-art science and insight into new developments in the fields of basic, clinical and therapeutic research in Hematology.

At the time it was founded, ESH was the only institution of its kind in the world. Since then, a number of other medical disciplines have adopted a similar model. But ESH remains unique in the field of hematology.

ESH tools for continuing education are produced by International experts in the field. They are available to scientists and clinicians free of charge and are used throughout the world to train hematologists.

ESH conferences are therefore designed to promote informal interaction and ample discussion with international experts in order to facilitate the processing of scientific information.

ESH also produces freely accessible training tools including interactive handbooks, thematic currical and conference webcasts: For more information, please refer to the ESH website (

5 - Agence de la Biomédecine

The French Agence de la biomédecine, established by the bioethics law in August 2004, is a French public administrative institution working under the responsibility of the French Ministry of Health; it oversees four key areas of human biology and medicine: organ tissue and cell transplantation, assisted reproductive technology, prenatal and genetic diagnosis and human embryo and embryonic stem cell research.

These medical activities all share major therapeutic, health and ethical issues. The Agence de la biomédecine is the sole agency in Europe that brings together the four areas of transplantation, procreation, embryology and genetics.

The Eurocord Registry was transferred to the Agence de la biomédecine, in July 2010.

For more information, please refer to the ABM website (

6 - Assistance Publique-Hôpitaux de Paris and Cord blood bank of the Hôpital Saint-Louis.

This structure represents the sole allogenic cord blood bank of the Assistance Publique-Hôpitaux de Paris (AP-HP). It was created by the cell therapy unit (UTC) of the Hopital Saint-Louis with the support of the AP-HP and Biomedicine Agency.

Historically, the collection and storage of umbilical cord blood were organized at the AP-HP in 1989 at Saint-Louis Hospital, in collaboration with the Maternity of the Hopital Saint Vincent de Paul. This "pilot” approach was developed in response to the first transplant of hematopoietic stem cells from umbilical cord blood, performed at St. Louis Hospital in 1988 in the BMT unit lead by Professor Eliane Gluckman.

Currently, the cord blood samples are collected in maternity of the hospitals: Robert Debré, Franco-British and Seine-Saint-Denis. Approximately 3,500 cord blood samples were taken over by the Cord Blood Bank in 2013. Today, more than 2,900 cord blood transplants that are stored in Saint-Louis Hospital.

The Cell therapy unit is accredited for its hematopoietic stem cell transplantation activity by: JACIE (Joint Accreditation Committee ISHAGE-Europe) since March 2005. It is also accredited by the
WMDA (World Marrow Donor Association) and by the
FDA (Food and Drug Administration)

The cell therapy unit is also licensed by the National Security Agency for Drugs and Health products (MSNA, formerly AFSSAPS).

A Biological Resource Centre (CRB), close to the Cord Blood Bank, was also created. Samples that do not fulfill the French Netcord criteria for therapeutic use in transplantation, can be used for research purpose. Today, the CRB allows the provision of qualified biologic products to more than 20 research teams in the Ile-de-France. CRB obtained the AFNOR certification.

For further information related to the cord blood bank, please visit the APHP website: For information regarding Cord blood donation, please refer to the attached document

7 - The International NetCord Foundation

The International NetCord Foundation is a non-profit association of umbilical cord blood banks whose members comprise the largest source of high-quality cord blood grafts for patients in need of hematopoietic stem cell transplantation. Established in 1997, NetCord currently has nearly 35 member banks and registries with an inventory that exceeds 211,000 units, representing about 51% of the global supply of publicly banked cord blood.

NetCord sponsors standards and accreditation for umbilical cord blood banks. It also promotes studies and research on cord blood collection processes, the characterization and preservation of cells, ex-vivo expansion of placental and umbilical cord blood, and quality improvement of blood components for clinical cellular therapy.

To ensure high and uniform quality of all cord blood units in its inventory, NetCord published in 2000, with the Foundation for the Accreditation of Cellular Therapy (FACT), the first NetCord-FACT International Standards for Cord Blood Collection, Processing, Testing, Banking, Selection and Release. Today the Standards are universally recognized by stem cell transplant programs.

For further information, please refer to the WBMT website (

8 - The European Group for Blood and Marrow Transplantation (EBMT)

The EBMT is a non-profit organisation that was established in 1974 in order to allow scientists and physicians involved in clinical bone marrow transplantation to share their experience and develop co-operative studies. The EBMT is devoted to the promotion of all aspects associated with the transplantation of haematopoietic stem cells from all donor sources and donor types including basic and clinical research, education, standardisation, quality control, and accreditation for transplant procedures.

For further information, please refer to the EBMT website (

9 - The Center for International Blood and Marrow Transplant Research

The CIBMTR collaborates with the global scientific community to advance hematopoietic cell transplantation (HCT) and cellular therapy research worldwide. A research program of the National Marrow Donor Program®/Be the Match and the Medical College of Wisconsin; CIBMTR facilitates critical research that has led to increased survival and an enriched quality of life for thousands of patients.

The CIBMTR prospective and observational research is accomplished through scientific and statistical expertise; a large network of transplant centers and a clinical database of more than 390,000 transplant recipients. Support for the program is provided, in part, by grants and contracts from the National Institute of Health and Health Resources and Services Administration. Successful use of this funding has resulted in the completion of hundreds of studies that positively impact both clinical practice and transplant patients. The CIBMTR has a long history of robust and collaborative partnership with Eurocord.

For further information, please refer to the CIBMTR website ( )

10 - The National Marrow Donor Program® (NMDP)

Founded in 1987 by the federal government, the National Marrow Donor Program (NMDP) and its Be The Match Registry are nonprofit organizations dedicated to creating an opportunity for all patients to receive the bone marrow or umbilical cord blood transplant they need, when they need it. As trusted leaders in advancing treatments for those facing life-threatening blood cancers, the NMDP provides the ground-breaking research, innovative technologies, patient support and education that save lives.

For further information, please refer to the NMDP website:

11 - The Worldwide Network for Blood & Marrow Transplantation (WBMT)

The WBMT is a nonprofit scientific organization with the mission to promote excellence in stem cell transplantation, stem cell donation and cellular therapy. The purpose of this cooperation is to engage exclusively in scientific and educational activities and endeavours.

For further information, please refer to the WBMT website (

12 - The World Marrow Donor Association (WMDA)

The World Marrow Donor Association (WMDA) is a voluntary organisation of representatives of blood stem cell donor registries, cord blood banks, and other organisations and individuals with an interest in blood stem cell transplantation. It provides a forum for discussion of issues regarding the clinical use of blood stem cells from unrelated donors across international boundaries and for formulation of guidelines on logistics, quality control, ethics, finances, information technology and registry accreditation.

WMDA was initiated as a programme in 1988 by three pioneers in the field of transplantation: John Goldman (UK), E. Donnell Thomas (US) and Jon J. van Rood (NL). This led to the foundation of WMDA in 1994. Since then, WMDA has grown into a global association, representing 73 donor registries, 158 cord blood banks, 350 donor centres, and 1,615 transplant hospitals from 52 different countries.

For further information, please refer to the WBMT website

13 - L’Association Cordons de Vie

The association ‘Cordons de Vie’ was founded in July 2012 by Doctor Fabienne Mourou with the following missions:

To support medical research related to the use of umbilical cord blood stem cells for the treatment of hematologic diseases as well as for regenerative medicine.

To develop the use of available effective treatments for leukemia, lymphoma and sickle cell anemia also in Europe and in Africa and help the patients with limited resources to benefit from standard treatment.

To promote, in collaboration with Monaco’s maternity team, the establishment of a bio-resource center in the Principality, to face the critical shortage in stem cell grafts and the increasingly important international needs.

ESH also produces freely accessible training tools including interactive handbooks, thematic currical and conference webcasts: For more information, please refer to the ESH website (

Words of president
- Eliane Gluckman -

Major improvement has been observed in the field of hematopoietic stem cell...
Read more

Eurocord Monaco

MONACORD is a clinical research organisation, which has established at the Centre Scientifique de Monaco

Read more